UOC
CME icon

UBS O'Connor’s CME Group CME Stock Holding History

UBS O'Connor’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-16,000
Closed -$2.83M – 67
2022
Q3 		$2.83M Buy
16,000
+11,000
+220% +$2.17M 0.03% 452
2022
Q2 		$1.02M Buy
+5,000
New +$1.06M 0.01% 761
2021
Q2 		– Sell
-15,000
Closed -$3.06M – 889
2021
Q1 		$3.06M Buy
+15,000
New +$2.95M 0.04% 371
2017
Q4 		– Sell
-33,700
Closed -$4.57M – 308
2017
Q3 		$4.57M Buy
+33,700
New +$4.26M 0.07% 200
2016
Q1 		– Sell
-9,000
Closed -$815K – 454
2015
Q4 		$815K Sell
9,000
-20,599
-70% -$1.94M 0.01% 332
2015
Q3 		$2.75M Buy
29,599
+13,071
+79% +$1.24M 0.06% 263
2015
Q2 		$1.54M Buy
+16,528
New +$1.54M 0.03% 345

Other funds holding CME

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

UBS O'Connor's CME Position: Q4 2022 in Review

UBS O'Connor sold out of CME Group (CME) in Q4 2022, closing a stake of 16,000 shares — an estimated $2.83M sold.

UBS O'Connor first reported a position in CME in Q2 2015 and held it in 7 quarters. The position peaked at $4.57M in Q3 2017. 1,149 funds tracked by Wall St. Rank hold CME as of Q4 2022.

  • UBS O'Connor reported no remaining CME Group position as of Q4 2022 after selling out during the quarter.
  • UBS O'Connor sold 16,000 CME Group shares in Q4 2022, an estimated $2.83M.
  • UBS O'Connor first reported a position in CME Group in Q2 2015 and held it in 7 quarters.
  • UBS O'Connor's CME Group position peaked at $4.57M in Q3 2017.
  • 1,149 funds tracked by Wall St. Rank held CME Group as of Q4 2022.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.